Abstract
AimsThe hereditary β-thalassemia major condition requires regular lifelong blood transfusions. Transfusion-related iron overloading has been associated with the onset of cardiovascular complications, including cardiac dysfunction and vascular anomalies. By using an untransfused murine model of β-thalassemia major, we tested the hypothesis that vascular endothelial dysfunction, alterations of arterial structure and of its mechanical properties would occur despite the absence of treatments.Methods and ResultsVascular function and structure were evaluated ex vivo. Compared to the controls, endothelium-dependent vasodilation with acetylcholine was blunted in mesenteric resistance arteries of β-thalassemic mice while the endothelium-independent vasodilator (sodium nitroprusside) produced comparable vessel dilation, indicating endothelial cell impairment with preserved smooth muscle cell reactivity to nitric oxide (NO). While these findings suggest a decrease in NO bioavailability, Western blotting showed heightened expression of aortic endothelial NO synthase (eNOS) in β-thalassemia. Vascular remodeling of the common carotid arteries revealed increased medial elastin content. Under isobaric conditions, the carotid arteries of β-thalassemic mice exhibited decreased wall stress and softening due to structural changes of the vessel wall.ConclusionsA complex vasculopathy was identified in untransfused β-thalassemic mice characterized by altered carotid artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced NO bioavailability despite enhanced vascular eNOS expression.
Highlights
MethodsExperimental Animals Experimental procedures, including ex vivo sample analyses, were conducted in accordance with guidelines of the Institutional Animal Care Committee of the University of Montreal Hospital Research Center
A complex vasculopathy was identified in untransfused b-thalassemic mice characterized by altered carotid artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced nitric oxide (NO) bioavailability despite enhanced vascular endothelial NO synthase (eNOS) expression
HF was a recipient of the Programme canadien des bourses de la francophonie studentship and WL was a recipient of a Canadian Blood Services (CBS)/CIHR fellowship award
Summary
Experimental Animals Experimental procedures, including ex vivo sample analyses, were conducted in accordance with guidelines of the Institutional Animal Care Committee of the University of Montreal Hospital Research Center. Male homozygous b-thalassemic (homo-bthal, Hbbd3(th)/d3(th)) and bone marrow-transplanted control mice (Hbb+/+) were generated, as described previously [16]. Bone marrow cells harvested from either homozygous b-thalassemic (Hbbd3(th)/d3(th)) or wild type C57BL/6J-Gpi1a (Hbb+/+) donors were injected (1.86106 cells) into sub-lethally-irradiated (8.75 Gy, Mark I-68A-1 Research Irradiator, San Francisco, CA), 2-month-old C57BL/6J-Gpi1b recipients. Recipients displaying complete hematopoietic engraftment were included in the study, i.e. recipients with the sole expression of either hemoglobin minor for homo-bthal mice or the specific glucose phosphate isomerase isotype marker Gpi1a for the controls
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.